Human Rights

Respecting Human Rights

Respecting Human Rights

Sumitomo Dainippon Pharma respects the human rights of all people involved with the Company. In the "Declaration of Conduct: Item 5. Respect Human Rights", we clearly support the Universal Declaration of Human Rights and Core Labour Standards. And in the "Compliance Standard: Item 23. Prohibition of Harassment including Discrimination" clearly rejects any discrimination or harassment based on race, nationality, ethnicity, gender, age, religion, faith, belief, sexual orientation (LGBT), gender identity, academic background, disability, disease or form of employment.

Power harassment and sexual harassment in the workplace should be addressed as important issues that can relate to the violation of human rights. To prevent any harassment, Sumitomo Dainippon Pharma Office Regulations clearly stipulates anti-harassment policies including standards of disciplinary action.

Clinical Trials Put the Human Rights of Subjects First

We conduct human clinical studies in accordance with the requirements for new drug applications and with the utmost consideration to the subjects' human rights. Since clinical studies are conducted during the intermediate stages of confirming the efficacy (effectiveness) and safety (or side effects) of drug candidates, our clinical studies follow such regulations as Japan's ministerial ordinance on Good Clinical Practice (GCP), which was established to protect the human rights, maintain the safety and improve the welfare of subjects participating in studies.
In clinical studies, our guiding principle is "promotion of development activities based on common sense and conscience" while always keeping in mind the risk of unpredictable side effects. In all of our studies, we secure the safety of participants by collecting, reporting and evaluating all required information, including that necessary for judging whether each person will be able to safely meet the requirements for participation.

Initiatives to Prevent Harassment

Power harassment and sexual harassment in the workplace, as actions that hurt the dignity of individuals, are important issues related to the violation of human rights. In our in-house training, we provide education on the relationship between our business activities and human rights, deepening the understanding that each individual employee has about human rights. In our new employee training, we aim to foster awareness that respect for human rights is a part of drug research and development, manufacture and sales. Moreover, in addition to the acquisition of the proper knowledge and an emphasis on raising awareness about preventing harassment through grade-specific training and training for managers.

Initiatives to Prevent Harassment

We have set up consultation desks at our main business sites, including head office, creating an organization that can respond promptly and considerately to complaints and inquiries. All parties related to the company are eligible for these measures and the entire company is committed to preventing any harassment.

Human Rights for Supply Chain Labor Conditions

Consistent with the "Procurement Ethics", we continually engage in the promotion of CSR procurement to achieve "the prohibition of forced labor and child labor" and "the prohibition of discrimination and inhumane treatment."
Check here for "Procurement Ethics"

Relationship with the Labor Union

The Sumitomo Dainippon Pharma Labor Union comprises employees from the Sumitomo Dainippon Pharma and accedes to The Japanese Federation of Textile Chemical, Food, Commercial, Service and General Worker's Unions (UA Zensen), one of the largest industrial unions. As regular labor-management negotiation bodies, the Labor Union and the company proactively exchange opinions based on their each perspectives on human capital management and workplace health & safety.